Literature DB >> 28457700

Human Connexin40 Mutations Slow Conduction and Increase Propensity for Atrial Fibrillation.

Ajita Kanthan1, Peter Fahmy2, Renuka Rao2, Jim Pouliopoulos2, Ian E Alexander3, Stuart P Thomas2, Eddy Kizana2.   

Abstract

BACKGROUND: Patch clamping studies using non-cardiomyocytes revealed that the human connexin40 mutations P88S, G38D, and A96S are associated with reduced gap junction conductances compared to wild type connexin40 (wtCx40). Their effects within myocytes however are unclear. We aimed to characterise P88S, G38D, and A96S after expression in rat hearts and primary cardiomyocyte cultures.
METHODS: Adult Sprague-Dawley rat atria were transduced with a lentivector containing a transgene encoding wtCx40, P88S, G38D, A96S, or eGFP (n=6 per transgene). Electrophysiology studies (EPS) were performed just prior to and 7 days after surgery. Left atria were assessed for connexin expression, mRNA levels, inflammation and fibrosis. Primary cardiomyocyte cultures were also transduced with the abovementioned vectors (n=6 per transgene) and monolayer conduction velocities (CV) and protein expression were assessed at 96hours.
RESULTS: At day 7 EPS, P wave and induced atrial fibrillation (AF) durations were significantly longer in the mutant groups when compared to wtCx40 controls (p<0.05). There were no significant differences in inflammation, fibrosis, or heart to body weight ratios. Monolayer CV's were reduced in the A96S group compared to the wtCx40 group. While similar to wtCx40 controls, P88S velocities were reduced compared to eGFP controls. G38D monolayers possessed spontaneous fibrillatory activity and could not be paced. Immunofluorescence revealed that P88S and G38D reduced native connexin43 myocyte coupling while A96S appeared to co-localise with connexin43 in gap junctions. Connexin43 mRNA levels were similar between groups.
CONCLUSIONS: The A96S, G38D, and P88S Cx40 mutations slow conduction and increased the propensity for inducible AF. Crown
Copyright © 2017. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Cardiac electrophysiology; Connexin40; Gene mutation

Mesh:

Substances:

Year:  2017        PMID: 28457700     DOI: 10.1016/j.hlc.2017.02.010

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  5 in total

Review 1.  Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective.

Authors:  Stanley Nattel; Jordi Heijman; Liping Zhou; Dobromir Dobrev
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

2.  Whole genome and transcriptome sequencing of post-mortem cardiac tissues from sudden cardiac death victims identifies a gene regulatory variant in NEXN.

Authors:  Jeppe D Andersen; Stine B Jacobsen; Linea C Trudsø; Marie-Louise Kampmann; Jytte Banner; Niels Morling
Journal:  Int J Legal Med       Date:  2019-08-07       Impact factor: 2.686

3.  Connexins and Atrial Fibrillation in Obstructive Sleep Apnea.

Authors:  Abdelnaby Khalyfa; David Gozal
Journal:  Curr Sleep Med Rep       Date:  2018-10-26

4.  Differential Association of Cx37 and Cx40 Genetic Variants in Atrial Fibrillation with and without Underlying Structural Heart Disease.

Authors:  Sebastian Carballo; Anna Pfenniger; David Carballo; Nicolas Garin; Richard W James; François Mach; Dipen Shah; Brenda R Kwak
Journal:  Int J Mol Sci       Date:  2018-01-19       Impact factor: 5.923

5.  Lack of authentic atrial fibrillation in commonly used murine atrial fibrillation models.

Authors:  Fumin Fu; Michael Pietropaolo; Lei Cui; Shilpa Pandit; Weiyan Li; Oleg Tarnavski; Suraj S Shetty; Jing Liu; Jennifer M Lussier; Yutaka Murakami; Prabhjit K Grewal; Galina Deyneko; Gordon M Turner; Andrew K P Taggart; M Gerard Waters; Shaun Coughlin; Yuichiro Adachi
Journal:  PLoS One       Date:  2022-01-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.